647 related articles for article (PubMed ID: 24076634)
1. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW
Nat Immunol; 2013 Nov; 14(11):1173-82. PubMed ID: 24076634
[TBL] [Abstract][Full Text] [Related]
2. Bypassing T cell 'exhaustion'.
Göthert JR
Nat Immunol; 2013 Nov; 14(11):1114-6. PubMed ID: 24145784
[No Abstract] [Full Text] [Related]
3. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.
Liikanen I; Lauhan C; Quon S; Omilusik K; Phan AT; Bartrolí LB; Ferry A; Goulding J; Chen J; Scott-Browne JP; Yustein JT; Scharping NE; Witherden DA; Goldrath AW
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33792560
[TBL] [Abstract][Full Text] [Related]
4. HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection.
Liu R; Muliadi V; Mou W; Li H; Yuan J; Holmberg J; Chambers BJ; Ullah N; Wurth J; Alzrigat M; Schlisio S; Carow B; Larsson LG; Rottenberg ME
Nat Commun; 2022 Sep; 13(1):5093. PubMed ID: 36064840
[TBL] [Abstract][Full Text] [Related]
5. Suppression of T-cell expansion by melanoma is exerted on resting cells.
Russ AJ; Wentworth L; Xu K; Rakhmilevich A; Seroogy CM; Sondel PM; Suresh M; Cho CS
Ann Surg Oncol; 2011 Dec; 18(13):3848-57. PubMed ID: 21465311
[TBL] [Abstract][Full Text] [Related]
6. Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and Function.
Izquierdo HM; Brandi P; Gómez MJ; Conde-Garrosa R; Priego E; Enamorado M; Martínez-Cano S; Sánchez I; Conejero L; Jimenez-Carretero D; Martín-Puig S; Guilliams M; Sancho D
Cell Rep; 2018 Aug; 24(7):1738-1746. PubMed ID: 30110631
[TBL] [Abstract][Full Text] [Related]
7. VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.
Labrousse-Arias D; Martínez-Alonso E; Corral-Escariz M; Bienes-Martínez R; Berridy J; Serrano-Oviedo L; Conde E; García-Bermejo ML; Giménez-Bachs JM; Salinas-Sánchez AS; Sánchez-Prieto R; Yao M; Lasa M; Calzada MJ
J Cell Biol; 2017 Mar; 216(3):835-847. PubMed ID: 28235946
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
10. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
[TBL] [Abstract][Full Text] [Related]
11. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24
Minami T; Matsumura N; Sugimoto K; Shimizu N; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
Int Immunopharmacol; 2017 Mar; 44():197-202. PubMed ID: 28110220
[TBL] [Abstract][Full Text] [Related]
13. Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development.
Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Rankin EB; Giaccia AJ; Schipani E
Dev Biol; 2014 Sep; 393(1):124-36. PubMed ID: 24972088
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.
Huang LR; Wohlleber D; Reisinger F; Jenne CN; Cheng RL; Abdullah Z; Schildberg FA; Odenthal M; Dienes HP; van Rooijen N; Schmitt E; Garbi N; Croft M; Kurts C; Kubes P; Protzer U; Heikenwalder M; Knolle PA
Nat Immunol; 2013 Jun; 14(6):574-83. PubMed ID: 23584070
[TBL] [Abstract][Full Text] [Related]
15. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
Bartholdy C; Christensen JP; Wodarz D; Thomsen AR
J Virol; 2000 Nov; 74(22):10304-11. PubMed ID: 11044074
[TBL] [Abstract][Full Text] [Related]
16. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factors enhance glutamate signaling in cancer cells.
Hu H; Takano N; Xiang L; Gilkes DM; Luo W; Semenza GL
Oncotarget; 2014 Oct; 5(19):8853-68. PubMed ID: 25326682
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
20. Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8
Page N; Klimek B; De Roo M; Steinbach K; Soldati H; Lemeille S; Wagner I; Kreutzfeldt M; Di Liberto G; Vincenti I; Lingner T; Salinas G; Brück W; Simons M; Murr R; Kaye J; Zehn D; Pinschewer DD; Merkler D
Immunity; 2018 May; 48(5):937-950.e8. PubMed ID: 29768177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
